Kronenberg, Florian
Funding for this research was provided by:
Austrian Research Fund (W-1253 DK HOROS)
University of Innsbruck and Medical University of Innsbruck
Article History
Accepted: 10 January 2024
First Online: 22 January 2024
Declarations
:
: Florian Kronenberg reports receiving consulting or lecture fees from Novartis, Amgen, Silence Therapeutics, CRISPR Therapeutics and Roche.
: This article does not contain any studies with human or animal subjects performed by the author.